Movatterモバイル変換


[0]ホーム

URL:


News & Perspective
Drugs & Diseases
CME & Education
Video
Decision Point
Edition:English
Log In
Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    UnivadisfromMedscape
    RegisterLog In

    No Results

      No Results

        News & PerspectiveDrugs & DiseasesCME & EducationVideoDecision Point
        close
        Please confirm that you would like to log out of Medscape.If you log out, you will be required to enter your username and password the next time you visit.Log outCancel
        https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly92aWV3cmVmZXJlbmNlLms4cy5tZWRzY2FwZS5jb20vYXJ0aWNsZS83NzcwMjYtb3ZlcnZpZXc=

        processing....

        Balanitis

        Updated: Feb 12, 2025
        • Author: Mark J Leber, MD, MPH; Chief Editor: Erik D Schraga, MD more...
        Overview

        Practice Essentials

        Balanitis is inflammation of the glans penis and is a common condition that affects an estimated 3-11% of males. [1]Balanitis can occur in males at any age. Morbidity is associated with the complications of phimosis. [2,3,4]Balanitis involving the foreskin and prepuce is termedbalanoposthitis. According to European guidelines outlining the current management of balanoposthitis, the aims of management are to minimize sexual dysfunction and  urinary dysfunction, exclude penile cancer, treat premalignant disease, and diagnose and treat sexually transmitted infections. [5]

        Predisposing factors include poor hygiene and overwashing, use of over-the-counter medications, and nonretraction of the foreskin. [5]Though uncommon, a complication of balanitis (usually only in recurrent cases) is constrictingphimosis, or inability to retract the foreskin from the glans penis. Other complications of balanitis may include meatal stenosis and possible urethral strictures, urinary retention, and vesicoureteral reflux.

        Balanitis xerotica obliterans (BXO), or penile lichen sclerosus, is a progressive sclerosing inflammatory dermatosis of the glans penis and foreskin (see the image below). BXO is uncommon in children. [2,3,4,6,7,8]

        Balanitis xerotica obliterans (lichen sclerosus). Balanitis xerotica obliterans (lichen sclerosus). Courtesy of Wilford Hall Medical Center Slide collection.

        Uncircumcised men with poor personal hygiene are most affected by balanitis. Lack of aeration and irritation because of smegma and discharge surrounding the glans penis causes inflammation and edema. Though uncommon, complications of balanitis include phimosis and cellulitis.Meatal stenosis with urinary retention may rarely accompany balanitis. In very few cases, balanitis may contribute to the "buried penis syndrome." Diabetes is the most common underlying condition associated with adult balanitis. [9,10,11] Older age has been identified as a risk factor for candidal balanitis. 

        Zoon balanitis (balanitis circumscripta plasmacellularis) is an inflammatory condition that is thought to result from chronic irritation and that presents as a well-demarcated shiny erythematous patch or plaque over the genital mucosa. [11] It typically occurs in middle-aged and older men who are uncircumcised. Because Zoon balanitis often complicates other dermatoses — especially lichen sclerosus, but also precancerous lesions and cancer— its frequency, and even its existence as an independent entity, has been called into question. [5,12]

        eMedicine Logo
        Next:

        Etiology

        Diabetes mellitus is the most common underlying condition associated with balanitis in adults. [9]In a study of patients with type 2 diabetes mellitus, treatment withdapagliflozin (a selective sodium-glucose transporter–2 [SGLT2] inhibitor that increases urinary glucose excretion) was found to be associated with an increased risk of vulvovaginitis or balanitis, related to the induction of glucosuria. According to the authors, events were generally mild to moderate, were clinically manageable, and rarely led to discontinuation of treatment. For dapagliflozin 5 mg and 10 mg daily, infections were reported in 5.7% and 4.8% of patients, respectively, as compared to 0.9% in patients with type 2 diabetes who were given placebo. [13,14]

        Other causes include the following [15]:

        • Poor personal hygiene
        • Chemical irritants (eg, soap, petroleum jelly)
        • Edematous conditions, such as congestive heart failure (right-sided), cirrhosis, and nephrosis
        • Drug allergies (eg, tetracycline, sulfonamide)
        • Morbid obesity

        Pathogens that can cause balanitis include the following:

        • Candidal species (most commonly associated with diabetes)
        • Group B and group A beta-hemolytic streptococci
        • Neisseria gonorrhoeae
        • Chlamydia species
        • Anaerobes (eg,Bacteroides)
        • Human papillomavirus
        • Gardnerella vaginalis
        • Treponema pallidum (syphilis)
        • Trichomonal species
        • Borrelia vincentii andBorrelia burgdorferi
        eMedicine Logo
        Previous
         
         
        References
        1. Wray AA, Velasquez J, Leslie SW, Khetarpal S. Balanitis. 2025 Jan.[QxMD MEDLINE Link].[Full Text].

        2. Kuehhas FE, Miernik A, Weibl P, Schoenthaler M, Sevcenco S, Schauer I, et al. Incidence of Balanitis Xerotica Obliterans in Boys Younger than 10 Years Presenting with Phimosis.Urol Int. 2012 Dec 29.[QxMD MEDLINE Link].

        3. Mohammed A, Shegil IS, Christou D, Khan A, Barua JM. Paediatric balanitis xerotica obliterans: an 8-year experience.Arch Ital Urol Androl. 2012 Mar. 84(1):12-6.[QxMD MEDLINE Link].

        4. Boksh K, Patwardhan N. Balanitis xerotica obliterans: has its diagnostic accuracy improved with time?.JRSM Open. 2017 Jun. 8 (6):2054270417692731.[QxMD MEDLINE Link].

        5. [Guideline] Edwards SK, Bunker CB, van der Snoek EM, van der Meijden WI. 2022 European guideline for the management of balanoposthitis.J Eur Acad Dermatol Venereol. 2023 Jun. 37 (6):1104-1117.[QxMD MEDLINE Link].[Full Text].

        6. Pradhan A, Patel R, Said AJ, Upadhyaya M. 10 Years' Experience in Balanitis Xerotica Obliterans: A Single-Institution Study.Eur J Pediatr Surg. 2018 Aug 21.[QxMD MEDLINE Link].

        7. Charlton OA, Smith SD. Balanitis xerotica obliterans: a review of diagnosis and management.Int J Dermatol. 2018 Oct 12.[QxMD MEDLINE Link].

        8. Celis S, Reed F, Murphy F, Adams S, Gillick J, Abdelhafeez AH, et al. Balanitis xerotica obliterans in children and adolescents: a literature review and clinical series.J Pediatr Urol. 2014 Feb. 10 (1):34-9.[QxMD MEDLINE Link].

        9. Kalra S, Chawla A. Diabetes and balanoposthitis.J Pak Med Assoc. 2016 Aug. 66 (8):1039-41.[QxMD MEDLINE Link].

        10. Snodgrass W, Blanquel JS, Bush NC. Recurrence after management of meatal balanitis xerotica obliterans.J Pediatr Urol. 2017 Apr. 13 (2):204.e1-204.e6.[QxMD MEDLINE Link].

        11. Relhan V, Kumar A, Kaur A. Zoon's Balanitis - Update of Clinical Spectrum and Management.Indian J Dermatol. 2024 Jan-Feb. 69 (1):63-73.[QxMD MEDLINE Link].[Full Text].

        12. Watchorn RE, Doyle C, Kravvas G, Bunker CB. Zoon balanitis: not a distinct clinicopathological entity?.Clin Exp Dermatol. 2024 Nov 1.[QxMD MEDLINE Link].

        13. Johnsson KM, Ptaszynska A, Schmitz B, Sugg J, Parikh SJ, List JF. Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin.J Diabetes Complications. 2013 Sep-Oct. 27(5):479-84.[QxMD MEDLINE Link].

        14. Njomnang Soh P, Vidal F, Huyghe E, Gourdy P, Halimi JM, Bouhanick B. Urinary and genital infections in patients with diabetes: How to diagnose and how to treat.Diabetes Metab. 2015 Aug 28.[QxMD MEDLINE Link].

        15. Borelli S, Lautenschlager S. [Differential diagnosis and management of balanitis].Hautarzt. 2015 Jan. 66 (1):6-11.[QxMD MEDLINE Link].

        16. Hugh JM, Lesiak K, Greene LA, Pierson JC. Zoon's balanitis.J Drugs Dermatol. 2014 Oct. 13 (10):1290-1.[QxMD MEDLINE Link].

        17. Torchia D, Cappugi P. Photodynamic therapy for Zoon balanitis.Eur J Dermatol. 2014 Nov-Dec. 24 (6):707.[QxMD MEDLINE Link].

        18. Bakkour W, Chularojanamontri L, Motta L, Chalmers RJ. Successful use of dapsone for the management of circinate balanitis.Clin Exp Dermatol. 2014 Apr. 39 (3):333-5.[QxMD MEDLINE Link].

        19. Dayal S, Sahu P. Zoon balanitis: A comprehensive review.Indian J Sex Transm Dis. 2016 Jul-Dec. 37 (2):129-138.[QxMD MEDLINE Link].

        20. Homer L, Buchanan KJ, Nasr B, Losty PD, Corbett HJ. Meatal Stenosis in Boys following Circumcision for Lichen Sclerosus (Balanitis Xerotica Obliterans).J Urol. 2014 Jun 30.[QxMD MEDLINE Link].

        21. [Guideline] Pandya I, Shinojia M, Vadukul D, Marfatia YS. Approach to balanitis/balanoposthitis: Current guidelines.Indian J Sex Transm Dis. 2014 Jul-Dec. 35 (2):155-7.[QxMD MEDLINE Link].

        22. Georgala S, Gregoriou S, Georgala C, et al. Pimecrolimus 1% cream in non-specific inflammatory recurrent balanitis.Dermatology. 2007. 215(3):209-12.[QxMD MEDLINE Link].

        23. Zavras N, Christianakis E, Mpourikas D, Ereikat K. Conservative treatment of phimosis with fluticasone proprionate 0.05%: a clinical study in 1185 boys.J Pediatr Urol. 2009 Jun. 5(3):181-5.[QxMD MEDLINE Link].

        24. Ashfield JE, Nickel KR, Siemens DR, MacNeily AE, Nickel JC. Treatment of phimosis with topical steroids in 194 children.J Urol. 2003 Mar. 169(3):1106-8.[QxMD MEDLINE Link].

        25. Marques TC, Sampaio FJ, Favorito LA. Treatment of phimosis with topical steroids and foreskin anatomy.Int Braz J Urol. 2005 Jul-Aug. 31(4):370-4; discussion 374.[QxMD MEDLINE Link].

        26. Steadman B, Ellsworth P. To circ or not to circ: indications, risks, and alternatives to circumcision in the pediatric population with phimosis.Urol Nurs. 2006 Jun. 26(3):181-94.[QxMD MEDLINE Link].

        27. Van Howe RS. Neonatal circumcision and penile inflammation in young boys.Clin Pediatr (Phila). 2007 May. 46(4):329-33.[QxMD MEDLINE Link].

        Media Gallery
        • Balanitis xerotica obliterans (lichen sclerosus). Courtesy of Wilford Hall Medical Center Slide collection.
        of1
        Contributor Information and Disclosures
        Author

        Mark J Leber, MD, MPH Assistant Professor of Emergency Medicine in Clinical Medicine, Weill Cornell Medical College; Attending Physician, Lincoln Medical and Mental Health Center

        Mark J Leber, MD, MPH is a member of the following medical societies:American College of Emergency Physicians,American College of Physicians

        Disclosure: Nothing to disclose.

        Coauthor(s)

        Anuritha Tirumani, MD Research Coordinator, Department of Emergency Medicine, Brooklyn Hospital Center

        Disclosure: Nothing to disclose.

        Specialty Editor Board

        Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

        Disclosure: Received salary from Medscape for employment. for: Medscape.

        Richard H Sinert, DO Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Vice-Chair in Charge of Research, Department of Emergency Medicine, Kings County Hospital Center

        Richard H Sinert, DO is a member of the following medical societies:American College of Physicians,Society for Academic Emergency Medicine

        Disclosure: Nothing to disclose.

        Chief Editor

        Erik D Schraga, MD Staff Physician, Department of Emergency Medicine, Mills-Peninsula Emergency Medical Associates

        Disclosure: Nothing to disclose.

        Additional Contributors

        Edward Bessman, MD, MBA Chairman and Clinical Director, Department of Emergency Medicine, John Hopkins Bayview Medical Center; Assistant Professor, Department of Emergency Medicine, Johns Hopkins University School of Medicine

        Edward Bessman, MD, MBA is a member of the following medical societies:American Academy of Emergency Medicine,American College of Emergency Physicians,Society for Academic Emergency Medicine

        Disclosure: Nothing to disclose.

        What would you like to print?
        Medscape Logo
        Find Us On
        About
        About MedscapePrivacy PolicyEditorial PolicyCookiesManage PreferencesTerms of UseAdvertising PolicyHelp Center
        Membership
        Become a MemberAbout YouProfessional InformationNewsletters & AlertsAdvertiseMarket Research
        Medscape
        Editions
        EnglishDeutschEspañolFrançaisPortuguês
        All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.

        [8]ページ先頭

        ©2009-2025 Movatter.jp